Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

The Challenge of Unexplained Splenomegalies: Preliminary Data of the French Prospective Multi-Center Splenomegaly Study (SMS)

Guillaume Denis, MD, Laurence Sanhes, MD, Jean-Marc Ziza, MD PhD, Frederic Bauduer, MD PhD, Marc G. Berger, MD PhD, Regis T. Costello, MD PhD, Kawkab Mehdi, Martin Michaud, MD, Geoffrey Urbanski, MD, Christian Rose, MD PhD

Blood (2018) 132 (Supplement 1): 4815.

https://doi.org/10.1182/blood-2018-99-113123

Published: 2018

Journal Articles

Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency

Blood (2017) 130 (Supplement 1): 2194.

https://doi.org/10.1182/blood.V130.Suppl_1.2194.2194

Published: 2017

Journal Articles

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Blood (2017) 130 (Supplement 1): 1705.

https://doi.org/10.1182/blood.V130.Suppl_1.1705.1705

Published: 2017

Journal Articles

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Christian Rose, MD, Olivier Fitoussi, MD, Emmanuel Gyan, MD PhD, Maya Hacini, MD, Shanti Amé, MD, Bernadette Corront, MD, Odile Beyne-Rauzy, MD PhD, Didier Innocent Adiko, MD, Elena-Anca Loppinet, MD, Nadia Ali-Ammar, MD, Eric Wattel, MD PhD, Francois Dreyfus, MD, Stéphane Cheze, MD PhD

Blood (2016) 128 (22): 2008.

https://doi.org/10.1182/blood.V128.22.2008.2008

Published: 2016

Journal Articles

Markers of Oxidative Stress Do Not Correlate with Labile Plasma Iron Blood in Patients with Myelodysplastic Syndromes

Christian Rose, MD, Fathi Driss, Veronique Mansat De Mas, Odile Beyne-Rauzy, MD PhD, Emmanuel Gyan, MD PhD, Yongmin MA, Robert Hider, Pierre Fenaux, MD PhD, Carole Beaumont, PhD

Blood (2015) 126 (23): 2149.

https://doi.org/10.1182/blood.V126.23.2149.2149

Published: 2015

Journal Articles

Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

Blood (2014) 124 (21): 3042.

https://doi.org/10.1182/blood.V124.21.3042.3042

Published: 2014

Journal Articles

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Blood (2014) 124 (21): 3254.

https://doi.org/10.1182/blood.V124.21.3254.3254

Published: 2014

Journal Articles

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

Juliette Berger, PhD, Marie Vigan, PhD, Jérôme Stirnemann, PD, PhD Professor, Céline Bourgne, PhD, Alexandre Janel, PhD, Nadia Belmatoug, MD, Christian Rose, MD, Monia Bengherbia, Bruno Pereira, France Mentré, MD PhD Professor, Marc G Berger, MD PhD

Blood (2014) 124 (21): 1396.

https://doi.org/10.1182/blood.V124.21.1396.1396

Published: 2014

Journal Articles

Incidence of Atrx Mutations in Myelodysplastic Syndromes (MDS)

Blood (2014) 124 (21): 4629.

https://doi.org/10.1182/blood.V124.21.4629.4629

Published: 2014

Journal Articles

Prognostic Of IgD Myeloma In The Era Of Novel Agents

Blood (2013) 122 (21): 1880.

https://doi.org/10.1182/blood.V122.21.1880.1880

Published: 2013

Journal Articles

High Prevalence Of Aspirin-Resistance In Myeloproliferative Neoplasms

Jean-Loup Demory, MD, Judith Bruge, Nathalie Cambier, MD, Christian Rose, MD, Agnès Charpentier, MD

Blood (2013) 122 (21): 5250.

https://doi.org/10.1182/blood.V122.21.5250.5250

Published: 2013

Journal Articles

A New ALAS2 Mutation Inducing a Male Lethal X-Linked Sideroblastic Anemia

Christian Rose, MD, Claire Oudin, Martine Fournier, Alexandre Bouquet, Luca Inchiappa, Bernard Grandchamp, Laurent Gouya, Caroline Kannengiesser

Blood (2013) 122 (21): 2199.

https://doi.org/10.1182/blood.V122.21.2199.2199

Published: 2013

Journal Articles

The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism

Blood (2013) 122 (21): 2761.

https://doi.org/10.1182/blood.V122.21.2761.2761

Published: 2013

Journal Articles

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

Agnès Charpentier, MD, Stéphanie Devaux, Judith Bruge-Debreu, MD, Nathalie Cambier, MD, Christian Rose, MD, PhD, Jean-Loup Demory, MD

Blood (2011) 118 (21): 5166.

https://doi.org/10.1182/blood.V118.21.5166.5166

Published: 2011

Journal Articles

The Uptake of Recombinant Glucocerebrosidases by Blood Monocytes From Type 1 Gaucher Disease Patients Is Heterogeneous

Juliette Berger, Jérome Stirnemann, MD, PhD, Céline Bourgne, Bruno Pereira, Pascale Pigeon, Djazia Heraoui, Chantal Rapatel, Christian Rose, MD, PhD, Nadia Belmatoug, MD, Marc G Berger, MD, PhD

Blood (2011) 118 (21): 1102.

https://doi.org/10.1182/blood.V118.21.1102.1102

Published: 2011

Journal Articles

Hematologic Responses In Myelodysplastic Syndromes (MDS) Patients Treated with Deferasirox: An EPIC Post-Hoc Analysis Using International Working Group (IWG) 2006 Criteria

Norbert Gattermann, MD, Carlo Finelli, MD, Matteo Della Porta, MD, Pierre Fenaux, MD, PhD, Michael Stadler, MD, Agnès Guerci-Bresler, MD, Mathias Schmid, MD, Kerry Taylor, MD, Dominique Vassilieff, MD, Dany Habr, MD, Andrea Marcellari, MS, MT(ASCP), Bernard Roubert, PhD, Christian Rose, MD

Blood (2010) 116 (21): 2912.

https://doi.org/10.1182/blood.V116.21.2912.2912

Published: 2010

Journal Articles

High Response Rate and Improved Exercise Capacity and Quality of Life with a New Regimen of Darbepoetin Alfa (DAR) +/−G-CSF in Lower-Risk MDS : a Phase II Study.

Blood (2009) 114 (22): 3812.

https://doi.org/10.1182/blood.V114.22.3812.3812

Published: 2009

Journal Articles

Care Practices in Gaucher Disease: Results of a French Study.

Belmatoug Nadia, Nathalie Guffon, Jérôme Stirnemann, Christine Serratrice, Alain Robert, Christian Rose, MD, Padrazzi Bruno, Pierre Kaminsky

Blood (2009) 114 (22): 4441.

https://doi.org/10.1182/blood.V114.22.4441.4441

Published: 2009

Journal Articles

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Véronique Tintillier-Colin, Nathalie Cambier, MD, Emmanuelle Bourgeois-Petit, MD, Christian Rose, MD, Gérard Forzy, MD, Jean-Loup Demory, MD, Agnès Charpentier, MD

Blood (2009) 114 (22): 1906.

https://doi.org/10.1182/blood.V114.22.1906.1906

Published: 2009

Journal Articles

Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.

Christian Rose, MD, Sabine Brechignac, MD, Dominique Vassilief, MD, Odile Beyne-Rauzy, MD, A. Stamatoullas, MD, Dalila Larbaa, MD, Agnes Guerci, MD, L. Roy, MD, Lydia Dumazert, MD, Beatrice Mahe, MD, S. Cheze, MD, Bruno Quesnel, MD PD, Dominique Bordessoule, MD PD, Francois Dreyfus, MD PD, Pierre Fenaux, MD PD

Blood (2007) 110 (11): 249.

https://doi.org/10.1182/blood.V110.11.249.249

Published: 2007

NARROW

The Challenge of Unexplained Splenomegalies: Preliminary Data of the French Prospective Multi-Center Splenomegaly Study (SMS)

Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency

Dyserythropoiesis Evaluated By Red Score and Hepcidin/Ferritin Levels Predicts Response to Epoetin Zeta in Lower Risk MDS

Prospective Evaluation of the Effect of Deferasirox on Hematologic Response in Transfusion-Dependent Patients with Low-Risk MDS and Iron Overload: The Rythmex Study

Markers of Oxidative Stress Do Not Correlate with Labile Plasma Iron Blood in Patients with Myelodysplastic Syndromes

Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

Systemic Inflammatory and Autoimmune Diseases (SAID) Associated with MDS: A French Multicenter Retrospective Study

Persistence of Imiglucerase in Cell Compartment Explains Dosing Frequency of Every Two Weeks in Type 1 Gaucher Disease

Incidence of Atrx Mutations in Myelodysplastic Syndromes (MDS)

Prognostic Of IgD Myeloma In The Era Of Novel Agents

High Prevalence Of Aspirin-Resistance In Myeloproliferative Neoplasms

A New ALAS2 Mutation Inducing a Male Lethal X-Linked Sideroblastic Anemia

The Revised IPSS (IPSS-R) Predicts Response To Erythropoietic Stimulating agents (ESA) In Pts With Classical IPSS Low Or Intermediate-1 (int 1)- MDS: A Joint Retrospective Study Of The GFM, Düsseldorf Registry and Fism

The Phenotypic Profile of Circulating Microparticles Is Different in Polycythemia Vera and Secondary Erythrocytosis

The Uptake of Recombinant Glucocerebrosidases by Blood Monocytes From Type 1 Gaucher Disease Patients Is Heterogeneous

Hematologic Responses In Myelodysplastic Syndromes (MDS) Patients Treated with Deferasirox: An EPIC Post-Hoc Analysis Using International Working Group (IWG) 2006 Criteria

High Response Rate and Improved Exercise Capacity and Quality of Life with a New Regimen of Darbepoetin Alfa (DAR) +/−G-CSF in Lower-Risk MDS : a Phase II Study.

Care Practices in Gaucher Disease: Results of a French Study.

Elevated Circulating Platelet-Derived Microparticles in Ph1 Negative Chronic Myeloproliferative Disorders.

Positive Impact of Iron Chelation Therapy (CT) on Survival in Regularly Transfused MDS Patients. A Prospective Analysis by the GFM.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only